180 related articles for article (PubMed ID: 21292636)
21. Post-ovulatory ageing of the human oocyte and embryo failure.
Wilcox AJ; Weinberg CR; Baird DD
Hum Reprod; 1998 Feb; 13(2):394-7. PubMed ID: 9557845
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope.
Kovalevskaya G; Birken S; Kakuma T; Ozaki N; Sauer M; Lindheim S; Cohen M; Kelly A; Schlatterer J; O'Connor JF
J Endocrinol; 2002 Mar; 172(3):497-506. PubMed ID: 11874698
[TBL] [Abstract][Full Text] [Related]
23. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
[TBL] [Abstract][Full Text] [Related]
24. Association of urinary concentrations of phthalate metabolites and bisphenol A with early pregnancy endpoints.
Chin HB; Jukic AM; Wilcox AJ; Weinberg CR; Ferguson KK; Calafat AM; McConnaughey DR; Baird DD
Environ Res; 2019 Jan; 168():254-260. PubMed ID: 30321738
[TBL] [Abstract][Full Text] [Related]
25. Natural limits of pregnancy testing in relation to the expected menstrual period.
Wilcox AJ; Baird DD; Dunson D; McChesney R; Weinberg CR
JAMA; 2001 Oct; 286(14):1759-61. PubMed ID: 11594902
[TBL] [Abstract][Full Text] [Related]
26. Incidence of early loss of pregnancy.
Wilcox AJ; Weinberg CR; O'Connor JF; Baird DD; Schlatterer JP; Canfield RE; Armstrong EG; Nisula BC
N Engl J Med; 1988 Jul; 319(4):189-94. PubMed ID: 3393170
[TBL] [Abstract][Full Text] [Related]
27. Hormonal profiles of natural conception cycles ending in early, unrecognized pregnancy loss.
Baird DD; Weinberg CR; Wilcox AJ; McConnaughey DR; Musey PI; Collins DC
J Clin Endocrinol Metab; 1991 Apr; 72(4):793-800. PubMed ID: 2005203
[TBL] [Abstract][Full Text] [Related]
28. Timing of conception and the risk of spontaneous abortion among pregnancies occurring during the use of natural family planning.
Gray RH; Simpson JL; Kambic RT; Queenan JT; Mena P; Perez A; Barbato M
Am J Obstet Gynecol; 1995 May; 172(5):1567-72. PubMed ID: 7755073
[TBL] [Abstract][Full Text] [Related]
29. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby.
Wilcox AJ; Weinberg CR; Baird DD
N Engl J Med; 1995 Dec; 333(23):1517-21. PubMed ID: 7477165
[TBL] [Abstract][Full Text] [Related]
30. Hyperglycosylated hCG and pregnancy failures.
Cole LA
J Reprod Immunol; 2012 Mar; 93(2):119-22. PubMed ID: 22386126
[TBL] [Abstract][Full Text] [Related]
31. Fetal loss after implantation. A prospective study.
Miller JF; Williamson E; Glue J; Gordon YB; Grudzinskas JG; Sykes A
Lancet; 1980 Sep; 2(8194):554-6. PubMed ID: 6106737
[TBL] [Abstract][Full Text] [Related]
32. Early pregnancy wastage following late implantation of embryos after in-vitro fertilization and embryo transfer.
Hamori M; Stuckensen JA; Rumpf D; Kniewald T; Kniewald A; Marquez M
Hum Reprod; 1989 Aug; 4(6):714-7. PubMed ID: 2476462
[TBL] [Abstract][Full Text] [Related]
33. Recurrent pre-clinical pregnancy loss is unlikely to be a 'cause' of unexplained infertility.
Koot YE; Boomsma CM; Eijkemans MJ; Lentjes EG; Macklon NS
Hum Reprod; 2011 Oct; 26(10):2636-41. PubMed ID: 21784735
[TBL] [Abstract][Full Text] [Related]
34. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group.
Hum Reprod; 2000 Jul; 15(7):1446-51. PubMed ID: 10875887
[TBL] [Abstract][Full Text] [Related]
35. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of early pregnancy loss.
Ellish NJ; Saboda K; O'Connor J; Nasca PC; Stanek EJ; Boyle C
Hum Reprod; 1996 Feb; 11(2):406-12. PubMed ID: 8671233
[TBL] [Abstract][Full Text] [Related]
37. Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancy.
Lenton EA; Neal LM; Sulaiman R
Fertil Steril; 1982 Jun; 37(6):773-8. PubMed ID: 7115557
[TBL] [Abstract][Full Text] [Related]
38. Hyperglycosylated human chorionic gonadotropin as a predictor of ongoing pregnancy.
Brady PC; Farland LV; Racowsky C; Ginsburg ES
Am J Obstet Gynecol; 2020 Jan; 222(1):68.e1-68.e12. PubMed ID: 31401260
[TBL] [Abstract][Full Text] [Related]
39. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
Cameron IT; Baird DT
Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
[TBL] [Abstract][Full Text] [Related]
40. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
